Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Labetalol recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Labetalol (20 total). Check the affected lots below.

Most common reason: Sterility / contamination (10 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Labetalol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Labetalol recalls on record

none so far in 2026; 20 on record, newest first
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross contamination due to product carry over.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-0064-2023
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-1347-2022
Class II · Moderate risk

Labetalol 20mg

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Terminated Labeling / mix-up Avella of Deer Valley, Inc. Store 38 NDC 42852-822-71 D-0997-2019
Class III · Low risk

labetalol HCl injection 20 mg/4 mL

Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018

Terminated Stability / shelf life SCA Pharmaceuticals, LLC. NDC 70004-0700-28 D-0603-2018
Class II · Moderate risk

Labetalol Hydrochloride Injection

Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.

Terminated Packaging defect Hospira Inc. A Pfizer Company NDC 0409-2267-20 D-0576-2018
Class II · Moderate risk

Labetalol HCl all strengths

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Terminated Labeling / mix-up Advanced Pharma Inc. D-0836-2017
Class II · Moderate risk

labetalol HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0058-2017
Class II · Moderate risk

Labetalol HCl active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-746-2015
Class II · Moderate risk

Labetalol Hydrochloride 5mg/Ml Injectable 100 Ml 80 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1553-2012